全文获取类型
收费全文 | 8834篇 |
免费 | 403篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 251篇 |
妇产科学 | 129篇 |
基础医学 | 941篇 |
口腔科学 | 213篇 |
临床医学 | 520篇 |
内科学 | 2527篇 |
皮肤病学 | 133篇 |
神经病学 | 787篇 |
特种医学 | 390篇 |
外科学 | 1620篇 |
综合类 | 22篇 |
预防医学 | 170篇 |
眼科学 | 103篇 |
药学 | 445篇 |
中国医学 | 17篇 |
肿瘤学 | 999篇 |
出版年
2023年 | 55篇 |
2022年 | 116篇 |
2021年 | 205篇 |
2020年 | 109篇 |
2019年 | 185篇 |
2018年 | 205篇 |
2017年 | 188篇 |
2016年 | 243篇 |
2015年 | 211篇 |
2014年 | 327篇 |
2013年 | 345篇 |
2012年 | 548篇 |
2011年 | 594篇 |
2010年 | 378篇 |
2009年 | 302篇 |
2008年 | 484篇 |
2007年 | 515篇 |
2006年 | 529篇 |
2005年 | 582篇 |
2004年 | 563篇 |
2003年 | 494篇 |
2002年 | 508篇 |
2001年 | 142篇 |
2000年 | 147篇 |
1999年 | 165篇 |
1998年 | 106篇 |
1997年 | 82篇 |
1996年 | 71篇 |
1995年 | 63篇 |
1994年 | 60篇 |
1993年 | 49篇 |
1992年 | 71篇 |
1991年 | 65篇 |
1990年 | 73篇 |
1989年 | 81篇 |
1988年 | 56篇 |
1987年 | 43篇 |
1986年 | 36篇 |
1985年 | 30篇 |
1984年 | 27篇 |
1983年 | 23篇 |
1982年 | 30篇 |
1981年 | 21篇 |
1980年 | 16篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1977年 | 25篇 |
1976年 | 15篇 |
1974年 | 14篇 |
1967年 | 15篇 |
排序方式: 共有9317条查询结果,搜索用时 78 毫秒
131.
Takaaki Imamura Osamu Yokosuka Tetsuhiro Chiba Tatso Kanda Hiroshige Kojima Kenichi Fukai Fumio Imazeki Miki Nishimura Yasushi Saito Hiromitsu Saisho 《Leukemia & lymphoma》2005,46(6):915-917
We report the case of a 52-year-old woman with hepatitis B virus (HBV) reactivation during treatment for chronic graft vs. host disease (GVHD) after peripheral bone marrow transplantation (PBSCT) to treat chronic myelocytic leukemia. She was given cyclosporine and prednisolone orally to treat chronic GVHD after PBSCT. Liver dysfunction first developed 25 months after transplantation with the appearance of hepatitis B s antigen (HBsAg), hepatitis B e antigen (HBeAg), and elevation of HBV-DNA up to 4.5 log copies/ml. Retrospective examination of her serum before PBSCT proved negative for HBsAg and HBeAg, and positive for anti-HBsAg, anti-HBeAg, anti-hepatitis B core antigen, and HBV-DNA (2.7 log copies/ml), showing that she was in a state of occult HBV infection. Nucleotide sequences of the HBV genome obtained from her serum showed no core promoter mutations at nt 1762 and 1764 and no pre-core mutation at nt 1896. Polymerase chain reaction-restriction fragment length polymorphism showed that she was infected with HBV genotype B. The administration of lamivudine, a nucleoside analog, improved her liver function and reduced HBV-DNA replication. We conclude that antiviral agents, such as lamivudine, are effective for treating hepatitis B reactivation during immunosuppressive treatment, such as for GVHD. The administration of a nucleoside analog before transplantation should also be considered in the light of HBV genotypes and mutations, even if HBsAg was negative and the viral load was low before transplantation. 相似文献
132.
Gender difference in alcoholic liver injury] 总被引:1,自引:0,他引:1
Nobuyuki Enomoto Yoshiyuki Takei Shunhei Yamashina Kenichi Ikejima Satoko Suzuki Tsuneo Kitamura Nobuhiro Sato 《Nihon Arukōru Yakubutsu Igakkai zasshi》2004,39(3):163-167
Gender differences of alcoholic liver injury have been described previously, but mechanisms have only partially characterized. For example, it is known that females develop alcoholic liver injury more rapidly and to a greater extent than males. It now appears that estrogen participates in several aspects of this phenomenon. On the other hand, attention has been directed towards the effect of ethanol ingestion on Kupffer cell function, which is stimulated by gut-derived endotoxins via mechanisms dependent on increased gut permeability and the possible relationship between Kupffer cell and alcohol-induced liver injury. 相似文献
133.
Ishikawa N Oda M Hashizume T Ishikawa T Kawase Y Sawa S 《Kyobu geka. The Japanese journal of thoracic surgery》2000,53(13):1137-1140
A 58-year-old man was admitted to our hospital because of chest pain and dyspnea on July 15, 1999. A chest X-ray showed left pleural effusion, and a chest CT revealed left pleural effusion and diffuse pleural thickening. Because pleural fluid cytology and percutaneous needle pleural biopsy were negative for malignancy, thoracoscopic biopsy was performed on July 28. The biopsied specimen revealed malignant pleural mesothelioma (epithelial type). An operation was performed on August 16. First, mediastinal lymph node dissection was performed and we identified that there was no lymph node metastasis by frozen section diagnosis. Then panpleuropneumonectomy with combined resection of the diaphragm and pericardium was performed. 相似文献
134.
Kenichi Satoh Mami Chikuda Ayako Ohashi Miho Kumagai Akiyoshi Kuji Shigeharu Joh 《Journal of clinical monitoring and computing》2016,30(4):423-428
Measurement of end-tidal carbon dioxide (PETCO2) is useful because of its noninvasiveness, continuity, and response time when sudden changes in ventilation occur during inhalation sedation. We compared the accuracy of PETCO2 using a nasal mask and nasal cannula with the accuracy of transcutaneous carbon dioxide (TC-CO2) and determined which method is more useful during inhalation sedation in volunteers. We used a modified nasal mask (MNM) and modified nasal cannula (MNC) for measurement of PETCO2. The capnometer measured PETCO2 in the gas expired from the nasal cavity by means of two devices. The volunteers received supplemental O2 by means of each device at a flow rate of 6 L/min. After the volunteers lay quietly for 5 min with a supply of 100 % O2, they received supplemental N2O by means of each device at concentrations of 10, 20, and 25 % for 5 min and 30 % for 25 min. The correlation coefficient was poorer in the MNM than in the MNC, and the mean difference between TC-CO2 and PETCO2 in the MNM was greater than that in the MNC. The difference between the TC-CO2 and PETCO2 ranged from 3 to 6 mmHg in the MNM and from 2 to 5 mmHg in the MNC. The difference between two variables against the TC-CO2 and the CO2 waveforms obtained by means of the two devices were within the clinically acceptable range. Our two devices can provide continuous monitoring of PETCO2 with a supply of N2O/O2 in patients undergoing inhalation sedation. 相似文献
135.
136.
137.
High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer
Reiko Iwadate Jun Inoue Hitoshi Tsuda Masashi Takano Kenichi Furuya Akira Hirasawa Daisuke Aoki Johji Inazawa 《ACTA HISTOCHEMICA ET CYTOCHEMICA》2014,47(6):295-301
High expression of SQSTM1/p62 (p62) protein, which functions as a hub for various cellular signaling pathways, has been detected in several human cancers. However, the clinicopathological impact of high p62 expression is largely unknown in epithelial ovarian cancer (EOC). Here, the expression level of p62 in primary EOCs (n=266) was assessed by immunohistochemistry, and its clinical significance was analyzed. Univariate and multivariate analyses were used to determine the impact of p62 expression on overall survival. p62 was expressed in the cytoplasm (Cyto) and/or nucleus (Nuc) in primary EOCs, and an expression subtype (CytoHigh/NucLow), showing high expression in the cytoplasm but low expression in the nucleus, was significantly correlated with serous carcinoma (P<0.001), advanced stage (P=0.005), presence of residual tumor (P<0.001), and low overall survival rate (P=0.013). Furthermore, in serous carcinomas (n=107), the p62 CytoHigh/NucLow subtype was significantly correlated with low overall survival rate (P=0.019) as an independent factor (P=0.044). Thus, our findings suggest that high expression of cytoplasmic p62 may be a novel prognostic biomarker in EOC, particularly in serous carcinoma. 相似文献
138.
Sei‐ichiro Motegi Yoko Yokoyama Akihiko Uchiyama Sachiko Ogino Yuko Takeuchi Kazuya Yamada Tomoyasu Hattori Hiroaki Hashizume Yuichi Ishikawa Makoto Goto Osamu Ishikawa 《The Journal of dermatology》2014,41(12):1047-1052
Atypical progeroid syndrome (APS), including atypical Werner syndrome (AWS), is a progeroid syndrome involving heterozygous mutations in the LMNA gene encoding the nuclear protein lamin A/C. We report the first Japanese case of APS/AWS with a LMNA mutation (p.D300N). A 53‐year‐old Japanese man had a history of recurrent severe cardiovascular diseases as well as brain infarction and hemorrhages. Although our APS/AWS patient had overlapping features with Werner syndrome (WS), such as high‐pitched voice, scleroderma, lipoatrophy and atherosclerosis, several cardinal features of WS, including short stature, premature graying/alopecia, cataract, bird‐like face, flat feet, hyperkeratosis on the soles and diabetes mellitus, were absent. In immunofluorescence staining and electron microscopic analyses of the patient's cultured fibroblasts, abnormal nuclear morphology, an increase in small aggregation of heterochromatin and a decrease in interchromatin granules in nuclei of fibroblasts were observed, suggesting that abnormal nuclear morphology and chromatin disorganization may be associated with the pathogenesis of APS/AWS. 相似文献
139.
140.
Katsuyoshi Horibata Akiko Ukai Takafumi Kimoto Tetsuya Suzuki Nagisa Kamoshita Kenichi Masumura Takehiko Nohmi Masamitsu Honma 《Environmental and molecular mutagenesis》2013,54(9):747-754
The recently developed Pig‐a mutation assay is based on flow cytometric enumeration of glycosylphosphatidylinositol (GPI) anchor‐deficient red blood cells caused by a forward mutation in the Pig‐a gene. Because the assay can be conducted in nontransgenic animals and the mutations accumulate with repeat dosing, we believe that the Pig‐a assay could be integrated into repeat‐dose toxicology studies and provides an alternative to transgenic rodent (TGR) mutation assays. The capacity and characteristics of the Pig‐a assay relative to TGR mutation assays, however, are unclear. Here, using transgenic gpt delta mice, we compared the in vivo genotoxicity of single oral doses of N‐ethyl‐N‐nitrosourea (ENU, 40 mg/kg), benzo[a]pyrene (BP, 100 and 200 mg/kg), and 4‐nitroquinoline‐1‐oxide (4NQO, 50 mg/kg) in the Pig‐a (peripheral blood) and gpt (bone marrow and liver) gene mutation assays. Pig‐a assays were conducted at 2, 4, and 7 weeks after the treatment, while gpt assays were conducted on tissues collected at the 7‐week terminal sacrifice. ENU increased both Pig‐a and gpt mutant frequencies (MFs) at all sampling times, and BP increased MFs in both assays but the Pig‐a MFs peaked at 2 weeks and then decreased. Although 4NQO increased gpt MFs in the liver, only weak, nonsignificant increases (two‐ or threefold above control) were detected in the bone marrow in both the Pig‐a and the gpt assay. These findings suggest that further studies are needed to elucidate the kinetics of the Pig‐a mutation assay in order to use it as an alternative to the TGR mutation assay. Environ. Mol. Mutagen. 54:747–754, 2013. © 2013 Wiley Periodicals, Inc. 相似文献